Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
United Kingdom | Publication | October 2024
On October 10, 2024, the Pensions Ombudsman published a blog marking “Ombuds Day”, as an opportunity to raise awareness and understanding of Ombudsman services.
The blog outlines that Ombudsman decisions are legally binding, the Ombudsman can make unlimited awards, and that it encourages resolution through local dispute handling processes wherever possible, before the need arises for its involvement.
The blog notes that demand for the Ombudsman’s service has increased and the types of complaints dealt with has become more complex.
In response to longer waiting times, the Ombudsman launched its Operating Model Review at the start of 2024. This aims to deliver a 25 per cent improvement in efficiency across the organisation over the next three years, with a specific focus on reducing waiting times.
Several new factsheets were published in October:
How we investigate complaints setting out information on what happens when a complaint is received and the steps the Ombudsman takes.
The Resolution Team which explains what it is, how it operates and options the parties to a complaint have.
Complaining to the party/parties at fault which explains how to use a scheme’s independent dispute resolution process before contacting the Ombudsman.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Africa faces a stark reality: contributing less than 4% of global greenhouse gas emissions, the continent is disproportionately impacted by climate change, threatening its development and stability.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023